GO:1902254 negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902254 describes any process that stops, prevents, or reduces the frequency, rate, or extent of the intrinsic apoptotic signaling pathway triggered by p53 class mediators.
• The term sits at the intersection of p53-driven apoptosis and its negative control, a balance critical for cancer suppression and therapy response.
• Senescence-like cell cycle arrest, a p53-dependent process, is mechanistically linked to negative regulation of intrinsic apoptosis, allowing damaged cells to survive without dividing.
• Key regulators include p53 itself, MDM2, MDMX, BCL-2 family proteins, and HIC1, whose genetic variants can alter apoptotic thresholds.
• Dysregulation of this process contributes to tumorigenesis, chemoresistance, and neurodegeneration, making it a high-value target for CRISPR-based disease modeling.
• Studying GO:1902254 requires integrated approaches: knockout, point-mutation, knock-in, and overexpression cell models coupled with functional apoptosis assays.
Description
The intrinsic apoptotic signaling pathway by p53 class mediator is a canonical tumor-suppressive mechanism that eliminates cells with irreparable DNA damage or oncogenic stress. However, cells also possess negative regulatory circuits that dampen this pathway, allowing survival under specific physiological or pathological conditions. GO:1902254, negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator, captures these inhibitory processes. Understanding this term is essential because the balance between p53-mediated apoptosis and its negative regulation determines cell fate in cancer, aging, and degenerative diseases. Researchers studying senescence-like cell cycle arrest have highlighted how p53 activity can be diverted from apoptosis toward survival, a phenomenon directly relevant to GO:1902254. Moreover, computational analyses of genes such as HIC1, a transcriptional repressor in the p53 network, reveal that single nucleotide polymorphisms can impact apoptotic regulation, underscoring the genetic complexity of this process. This article provides a research-grade overview of GO:1902254, integrating ontology data with published literature to guide experimental design and therapeutic hypothesis generation.
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator At A Glance
| GO ID | GO:1902254 |
|---|---|
| GO term | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| Ontology | biological_process |
| Synonym | inhibition of intrinsic apoptotic signaling pathway by p53 class mediator; downregulation of signal transduction by p53 class mediator resulting in induction of apoptosis |
| Major function | Suppression of p53-mediated intrinsic apoptosis, promoting cell survival |
| Related processes | Senescence-like cell cycle arrest, DNA damage response, tumor suppression |
| Key regulators | p53, MDM2, MDMX, BCL-2 family, HIC1 |
| Disease relevance | Cancer, chemoresistance, neurodegeneration |
What Is GO:1902254?
GO:1902254 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of the intrinsic apoptotic signaling pathway by p53 class mediator. In simpler terms, it encompasses all molecular events that put the brakes on p53-driven intrinsic apoptosis, thereby promoting cell survival under conditions where p53 would otherwise induce cell death.
Why Is negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator Important in Cell Biology?
GO:1902254 is critically important because it defines the cellular strategies that counteract p53-dependent apoptosis, a pathway that is frequently hijacked in cancer to evade cell death. Understanding how this negative regulation operates can reveal therapeutic vulnerabilities, especially in tumors that retain wild-type p53 but overexpress inhibitors of apoptosis. Additionally, this term is relevant to senescence-like cell cycle arrest, where cells survive despite p53 activation, contributing to aging and age-related pathologies. Genetic variations in regulators such as HIC1 can further modulate this process, highlighting the need for precise functional studies.
• Determines cell fate decisions between apoptosis and survival under p53-activating stress.
• Contributes to chemoresistance in cancers with functional p53 but enhanced anti-apoptotic signaling.
• Plays a role in senescence-like cell cycle arrest, linking apoptosis suppression to aging.
• Genetic polymorphisms in HIC1 may alter negative regulation of p53-mediated apoptosis.
• Provides a mechanistic basis for understanding tumor suppression escape.
• Offers targets for senolytic and chemosensitizing strategies.
• Essential for interpreting CRISPR screens aimed at identifying apoptosis regulators.
• Guides development of precision medicine approaches in oncology.
What Happens During negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator?
Initiation of p53-Mediated Apoptotic Signaling
In simple terms: When cells are stressed, p53 turns on genes that can kill the cell.
Under DNA damage or oncogenic stress, p53 is stabilized and activates transcription of pro-apoptotic BCL-2 family members such as PUMA and NOXA, leading to mitochondrial outer membrane permeabilization and caspase activation. This intrinsic apoptotic signaling by p53 class mediator is the target of negative regulation described by GO:1902254.
Negative Regulation by Anti-Apoptotic BCL-2 Proteins
In simple terms: Anti-apoptotic proteins block the killers, keeping cells alive.
BCL-2, BCL-xL, and MCL-1 bind and sequester pro-apoptotic effectors like BAX and BAK, preventing mitochondrial permeabilization and downstream caspase activation, thereby negatively regulating p53-mediated intrinsic apoptosis.
Inhibition of p53 Activity by MDM2/MDMX
In simple terms: MDM2 and MDMX put a brake on p53, reducing its ability to trigger apoptosis.
MDM2 ubiquitinates p53 for degradation, while MDMX binds and inhibits p53 transcriptional activity, collectively reducing the induction of pro-apoptotic genes and thus negatively regulating the intrinsic apoptotic pathway.
Role of Transcriptional Repressors like HIC1
In simple terms: HIC1 can silence genes that would otherwise promote apoptosis.
HIC1 is a transcriptional repressor that modulates p53-dependent responses; genetic variants in HIC1 may affect its function and thereby influence negative regulation of p53-mediated apoptosis.
Senescence-Like Cell Cycle Arrest as a Survival Outcome
In simple terms: Instead of dying, cells can enter a dormant-like state, which involves blocking apoptosis.
Senescence-like cell cycle arrest is a p53-dependent process where cells survive despite stress; negative regulation of intrinsic apoptosis is a key mechanism enabling this survival phenotype, as reviewed in the context of cancer.
Key Genes Involved in GO:1902254 negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator
The following genes and proteins are central to the negative regulation of the intrinsic apoptotic signaling pathway by p53 class mediator, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Induces intrinsic apoptosis via transcriptional activation of pro-apoptotic genes | Central mediator; mutations alter apoptotic threshold |
| MDM2 | E3 ubiquitin ligase that degrades p53 | Negative regulator; target for cancer therapy |
| MDMX | Binds and inhibits p53 transcriptional activity | Negative regulator; modulates apoptosis |
| BCL2 | Anti-apoptotic protein sequestering BAX/BAK | Overexpression blocks p53-mediated apoptosis |
| BCL2L1 | Encodes BCL-xL, anti-apoptotic | Inhibits mitochondrial permeabilization |
| MCL1 | Anti-apoptotic BCL-2 family member | Confers resistance to apoptosis |
| BAX | Pro-apoptotic effector | Its inhibition prevents apoptosis |
| BAK1 | Pro-apoptotic effector | Its inhibition prevents apoptosis |
| BBC3 | Encodes PUMA, pro-apoptotic | p53 target; its suppression reduces apoptosis |
| PMAIP1 | Encodes NOXA, pro-apoptotic | p53 target; its suppression reduces apoptosis |
| HIC1 | Transcriptional repressor in p53 network | SNPs may affect negative regulation |
| CASP3 | Executioner caspase | Downstream of mitochondrial permeabilization |
| CASP9 | Initiator caspase | Activated by cytochrome c release |
| APAF1 | Apoptosome component | Required for caspase-9 activation |
| CYCS | Cytochrome c, released from mitochondria | Triggers apoptosome formation |
| BIRC5 | Survivin, inhibitor of apoptosis | Negatively regulates apoptosis |
| XIAP | Inhibitor of apoptosis protein | Blocks caspase activity |
How Is negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator Regulated?
The negative regulation of intrinsic apoptotic signaling by p53 class mediator is itself tightly regulated. Key mechanisms include ubiquitin-proteasome-mediated degradation of p53 by MDM2, sequestration of pro-apoptotic proteins by anti-apoptotic BCL-2 family members, and transcriptional repression of pro-apoptotic genes by factors such as HIC1. Additionally, post-translational modifications of p53 and its regulators can shift the balance toward survival. Senescence-like cell cycle arrest represents a physiological context where this negative regulation is favored, as reviewed in cancer biology.
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer, Li-Fraumeni syndrome | Knockout or point-mutation cell lines |
| MDM2 | Tumorigenesis, chemoresistance | Overexpression and knockout models |
| BCL2 | Lymphoma, apoptosis evasion | Knock-in of anti-apoptotic variants |
| HIC1 | Cancer predisposition, epigenetic silencing | SNP knock-in via CRISPR |
| MCL1 | Multiple cancers, therapy resistance | Inducible knockout |
Cancer and Chemoresistance
Many cancers retain wild-type p53 but evade apoptosis by upregulating negative regulators such as BCL-2, MDM2, or MDMX, leading to chemoresistance. Targeting these negative regulators can restore p53-mediated apoptosis and sensitize tumors to therapy.
Senescence and Aging
Senescence-like cell cycle arrest, a p53-dependent process, is associated with aging and age-related diseases. Negative regulation of intrinsic apoptosis allows senescent cells to persist, contributing to tissue dysfunction.
Genetic Variation in HIC1
Computational analysis of single nucleotide polymorphisms in HIC1 suggests that genetic variants may alter its function as a transcriptional repressor, potentially impacting negative regulation of p53-mediated apoptosis and disease susceptibility.
From negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MDM2 enhance p53-mediated apoptosis? | MDM2 knockout cell line |
| Do HIC1 SNPs alter apoptotic threshold? | HIC1 point-mutation knock-in |
| Can BCL-2 overexpression block p53-induced apoptosis? | BCL-2 overexpression stable line |
| Is PUMA required for p53-mediated apoptosis? | PUMA knockout |
| Does senescence require negative regulation of apoptosis? | p53 knock-in mutants |
| Can CRISPR screen identify novel negative regulators? | Genome-wide CRISPR knockout library |
How to Study the negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine externalization | Quantify apoptosis |
| Caspase-3/7 luminescence | Caspase activity | Measure apoptosis execution |
| RNA-seq | Transcriptional changes | Identify p53 target genes |
| Proteomics | Protein abundance and interactions | Map apoptotic complexes |
| CRISPR knockout screen | Gene essentiality for apoptosis | Discover negative regulators |
| SNP functional prediction | Impact of variants on protein function | Prioritize HIC1 variants |
| Senescence-associated beta-galactosidase | Senescence induction | Link apoptosis suppression to senescence |
Apoptosis Assays
Annexin V staining, caspase-3/7 activity assays, and TUNEL are used to quantify apoptosis after p53 activation, allowing assessment of negative regulation.
Transcriptomics and Proteomics
RNA-seq and mass spectrometry can identify changes in pro- and anti-apoptotic gene expression and protein interactions following genetic perturbations.
CRISPR Screens
Genome-wide CRISPR knockout or activation screens can uncover novel negative regulators of p53-mediated apoptosis, as demonstrated in cancer research.
Computational SNP Analysis
In silico tools predict the impact of SNPs on protein function, as applied to HIC1, guiding functional validation.
How CRISPR Can Be Used to Study GO:1902254 negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator
Knockout
CRISPR knockout of negative regulators such as MDM2 or BCL-2 can sensitize cells to p53-mediated apoptosis, providing causal evidence for their role in GO:1902254.
Point Mutation
Introducing point mutations in p53 or HIC1 via CRISPR base editing or HDR allows precise testing of how specific residues or SNPs affect negative regulation of apoptosis.
Knock-in
Knock-in of tagged or mutant alleles (e.g., HIC1 variants) enables tracking of protein localization and function in the context of apoptotic regulation.
Overexpression
CRISPR activation or lentiviral overexpression of anti-apoptotic genes like BCL-2 can model the negative regulation of p53-mediated apoptosis observed in cancer.
How EDITGENE Supports negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator Research
Researchers studying negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator-related genes often need to determine whether a candidate gene is causally involved in suppressing apoptosis. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator research.
Frequently Asked Questions About negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator
What is GO:1902254?
GO:1902254 is a Gene Ontology term for any process that stops, prevents, or reduces the frequency, rate, or extent of the intrinsic apoptotic signaling pathway by p53 class mediator.
What genes are involved in negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator?
Key genes include TP53, MDM2, MDMX, BCL2, BCL2L1, MCL1, and HIC1, among others.
How does p53 induce intrinsic apoptosis?
p53 transcriptionally activates pro-apoptotic BCL-2 family members like PUMA and NOXA, leading to mitochondrial permeabilization and caspase activation.
What is the role of MDM2 in this process?
MDM2 ubiquitinates p53 for degradation, thereby reducing p53-mediated apoptosis and acting as a negative regulator.
Can CRISPR be used to study GO:1902254?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the regulators of this pathway.
What diseases are associated with dysregulation of this pathway?
Cancer, chemoresistance, and senescence-related pathologies are linked to altered negative regulation of p53-mediated apoptosis.
How do HIC1 variants affect apoptosis?
Computational analysis suggests that SNPs in HIC1 may alter its repressor function, potentially impacting negative regulation of p53-mediated apoptosis.
What experimental methods measure negative regulation of intrinsic apoptosis?
Annexin V staining, caspase activity assays, RNA-seq, proteomics, and CRISPR screens are commonly used.
What is senescence-like cell cycle arrest?
It is a p53-dependent state where cells survive but stop dividing, often involving negative regulation of apoptosis.
How can EDITGENE help my research on GO:1902254?
EDITGENE provides custom CRISPR cell models, library screening, and bioinformatics to study this pathway efficiently.
Conclusion
GO:1902254 encapsulates the critical balance between p53-driven apoptosis and cellular survival mechanisms. Understanding its regulators offers insights into cancer, aging, and therapeutic resistance. Leveraging CRISPR technologies and multi-omics approaches will continue to unravel the complexities of this pathway, paving the way for novel interventions.
References
- 1. Zarneshan SN et al.. 2023. Exploiting pivotal mechanisms behind the senescence-like cell cycle arrest in cancer.. Adv Protein Chem Struct Biol 135:1-19 PMID: 37061329
- 2. Annanya A et al.. 2024. Computational Analysis of Single Nucleotide Polymorphisms in Human HIC1 Gene.. Cureus 16(3):e56664 PMID: 38646326
